Suppr超能文献

HTT CAG 重复序列中 CAA 中断缺失的频率及其对低外显率亨廷顿病的影响。

Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range.

机构信息

Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, Canada.

Department of Human Genetics, Medical Faculty, Ruhr University of Bochum, Bochum, Germany.

出版信息

Genet Med. 2020 Dec;22(12):2108-2113. doi: 10.1038/s41436-020-0917-z. Epub 2020 Aug 3.

Abstract

PURPOSE

In some Huntington disease (HD) patients, the "loss of interruption" (LOI) variant eliminates an interrupting codon in the HTT CAG-repeat tract, which causes earlier age of onset (AOO). The magnitude of this effect is uncertain, since previous studies included few LOI carriers, and the variant also causes CAG size misestimation. We developed a rapid LOI detection screen, enabling unbiased frequency estimation among manifest HD patients. Additionally, we combined published data with clinical data from newly identified patients to accurately characterize the LOI's effect on AOO.

METHODS

We developed a LOI detection polymerase chain reaction (PCR) assay, and screened patients to estimate the frequency of the LOI variant and its effect on AOO.

RESULTS

Mean onset for LOI carriers (n = 49) is 20.4 years earlier than expected based on diagnosed CAG size. After correcting for CAG size underestimation, the variant is still associated with onset 9.5 years earlier. The LOI is present in 1.02% of symptomatic HD patients, and in 32.2% of symptomatic reduced penetrance (RP) range patients (36-39 CAGs).

CONCLUSION

The LOI causes significantly earlier onset, greater than expected by CAG length, particularly in persons with 36-39 CAG repeats. Detection of this variant has implications for HD families, especially for those in the RP range.

摘要

目的

在一些亨廷顿病(HD)患者中,“缺失中断”(LOI)变异消除了 HTT CAG 重复序列中的一个中断密码子,导致发病年龄更早(AOO)。由于以前的研究只包括少数 LOI 携带者,而且该变异也会导致 CAG 大小估计错误,因此这种影响的程度尚不确定。我们开发了一种快速的 LOI 检测筛选方法,能够在显性 HD 患者中进行无偏频率估计。此外,我们将已发表的数据与新发现的患者的临床数据相结合,准确地描述了 LOI 对 AOO 的影响。

方法

我们开发了一种 LOI 检测聚合酶链反应(PCR)检测方法,并对患者进行筛选,以估计 LOI 变体的频率及其对 AOO 的影响。

结果

携带 LOI 的患者(n=49)的平均发病年龄比根据诊断的 CAG 大小预计的早 20.4 年。在纠正 CAG 大小估计不足后,该变体仍然与发病年龄提前 9.5 年相关。LOI 存在于 1.02%的有症状 HD 患者和 32.2%的有症状低外显率(RP)范围患者(36-39 CAGs)中。

结论

LOI 导致发病年龄明显提前,超出 CAG 长度的预期,特别是在 36-39 CAG 重复的患者中。这种变异的检测对 HD 家族具有重要意义,尤其是对处于 RP 范围的家族。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1a/7708297/1ccafbefffaa/41436_2020_917_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验